What is HD?
HD operates within the dynamic medtech and healthcare solutions landscape, offering innovative products and services designed to enhance patient care and streamline healthcare operations. Based in Thailand, the company leverages its strategic location to address regional healthcare needs while aiming for broader market impact. Its focus on developing advanced healthcare solutions positions it as a key player in the evolving digital health ecosystem.
How much funding has HD raised?
HD has raised a total of $11.6M across 2 funding rounds:
Angel/Seed
$6M
Series A
$5.6M
Angel/Seed (2023): $6M with participation from AC Ventures, iSeed, and Partech International
Series A (2024): $5.6M led by FEBE Ventures, M Venture Partners, and SBI Ven Capital
Key Investors in HD
AC Ventures
AC Ventures is a growth equity investment firm specializing in high-growth, technology-enabled businesses across Southeast Asia, providing strategic guidance and operational expertise to scale businesses.
iSeed
iSeed offers a wide range of premium organic seeds and gardening supplies, focusing on high-quality, non-GMO products for passionate gardeners.
Partech International
Partech is a global investment firm that supports entrepreneurs at seed, venture, and growth stages across multiple continents, investing in a wide range of technologies and businesses.
What's next for HD?
With the recent influx of major strategic investment, HD is poised for accelerated growth and product development. The company is likely to focus on scaling its operations, expanding its market reach, and further enhancing its technological capabilities. This capital infusion will enable HD to solidify its position in the medtech industry, potentially exploring new partnerships and research initiatives to drive innovation in healthcare solutions. The company's strategic direction will likely involve leveraging its recent funding to achieve key milestones and deliver enhanced value to its stakeholders.
See full HD company page
